5 April 2016   But absolute risk remains low overall, finds large British study. by Parker Brown Staff Writer, MedPage Today   Pioglitazone (Actos) was associated with a higher risk of bladder cancer than other diabetes drugs in a large population-based cohort study.   Researchers looked at about...

18 April 2012    Recently, two studies were published in the New England Journal of Medicine (NEMJ) providing compelling evidence that surgical methods of achieving weight loss can lead to better control of Type 1 diabetes mellitus (T1DM). It is well established that weight loss in an obese per...

15 September 2010 September 14, 2010 — The US Food and Drug Administration (FDA) will consider revising the labels of the osteoporosis drugs bisphosphonates in light of a new report stating that long-term bisphosphonate use may increase the risk for unusual femur fracture, the agency announced ...

14 July 2010  In the last 20 years, a vast amount of scientific knowledge has been gathered about how insulin-producing cells develop, function and survive in the normal human body and how they become compromised and destroyed in diabetic patients. In recent years, interest in diabetes has inten...